González Martín, A., Oza, A. M., Embleton, A. C., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., . . . Perren, T. J. (2019). Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer. Gynecol Oncol.
Citación estilo ChicagoGonzález Martín, Antonio, et al. "Exploratory Outcome Analyses According to Stage And/or Residual Disease in the ICON7 Trial of Carboplatin and Paclitaxel With or Without Bevacizumab for Newly Diagnosed Ovarian Cancer." Gynecol Oncol 2019.
Cita MLAGonzález Martín, Antonio, et al. "Exploratory Outcome Analyses According to Stage And/or Residual Disease in the ICON7 Trial of Carboplatin and Paclitaxel With or Without Bevacizumab for Newly Diagnosed Ovarian Cancer." Gynecol Oncol 2019.